Cue Biopharma, Inc is a biopharmaceutical company based in Brighton, MA that is focused on developing immunotherapies for the treatment of cancer. Their innovative biologics mimic the natural signals of the immune system, known as Cues, to activate tumor-specific T cells in the patient's body, enabling them to selectively attack cancer cells.
By harnessing the specificity and diversity of the human immune system, Cue Biopharma's therapies have the potential to provide a more effective response against cancer while preserving safety. Their approach aims to restore the patient's own immune system's capacity to fight cancer, offering a promising avenue for the development of novel cancer treatments.
Generated from the website